Live Breaking News & Updates on Organicell indian

Stay informed with the latest breaking news from Organicell indian on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Organicell indian and stay connected to the pulse of your community

Trial of potential COVID-19 therapy yields positive results

Organicell has announced the initial results from its India-based trial of the COVID-19 treatment Zofin look promising, plans to expand to more patients.
Clinical-stage biopharma firm Organicell Regenerative Medicine has announced positive results for a trial centered in India involving the first 10 COVID-19 patients treated with Zofin. The initial trial, conducted in conjunction with Organicell’s Indian partner CWI India, aimed to study the effects of the treatment on COVID-19 patients with moderate to severe cases.
The 10 initial trial participants were patients admitted and treated at three different facilities:
Narayana Hrudayalaya Hospital, Bangalore
Prime Indian Hospital, Chennai
According to researchers, all 10 patients have recovered from their symptoms, and all have been discharged. Organicell reports that based on the initial trial results, it will be expanded to another 65 patients with moderate to severe COVID-19, treated at the three hospitals over the next several weeks, with treatments expected to be completed by the end of June 2021.

India , Bangalore , Karnataka , Kerala , Chennai , Tamil-nadu , Organicell-indian , Indian-health-ministry , Indian-council-for-medical-research , Cnn , Organicell-regenerative-medicine , Hrudayalaya-hospital

100 percent recovery rate for COVID-19 patients treated with Zofin™

The first ten patients in a Phase I trial of Zofin™ have recovered, the trial will now expand with an additional 65 participants.

India , Bangalore , Karnataka , Chennai , Tamil-nadu , Matthew-roshan , Albert-mitrani , Organicell-indian , Indian-health-ministry , Indian-council-for-medical-research , Regenerative-medicine , Narayana-hrudayalaya-hospital